Inventor
BOTHE ULRICH
DE24 patents
⚠️ This page may combine multiple inventors who share the name “BOTHE ULRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
12 patentsUS10308634B2Jun 4, 2019
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG17 citations93
US9951086B2Apr 24, 2018
Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
Bayer Pharma AG21 citations84
US10793545B2Oct 6, 2020
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG7 citations82
US12006303B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US12006304B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US10435396B2Oct 8, 2019
2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs
Bayer Pharma AG7 citations71
US12559473B2Feb 24, 2026
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG0 citations61
US11992481B2May 28, 2024
Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases
Bayer Pharma AG0 citations53
US12459916B2Nov 4, 2025
Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
Bayer Pharma AG0 citations43
US10730856B2Aug 4, 2020
Benzimidazole derivatives as EP4 ligands
Bayer Pharma AG0 citations40
US9714266B2Jul 25, 2017
Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)
Bayer Pharma AG0 citations38
US9512169B2Dec 6, 2016
3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
Bayer Pharma AG0 citations38
BAYER SCHERING PHARMA AG
3 patentsUS7897626B2Mar 1, 2011
2-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals
BAYER SCHERING PHARMA AG2 citations61
US7825128B2Nov 2, 2010
Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
BAYER SCHERING PHARMA AG7 citations60
US7250408B2Jul 31, 2007
Glucocorticoid receptor antagonists for prophylaxis and therapy of glucocorticoid-mediated hypogonadism, of sexual dysfunction and/or infertility
BAYER SCHERING PHARMA AG0 citations50
SCHERING AG
3 patentsUS7419972B2Sep 2, 2008
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
SCHERING AG2 citations58
US7199115B2Apr 3, 2007
17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
SCHERING AG0 citations51
US7408060B2Aug 5, 2008
Nonsteroidal progesterone receptor modulators
SCHERING AG0 citations39